Tag: Cosmetic risks

The US Food and Drug Administration (FDA) first approved topical bimatoprost (marketed as Latisse) for eyelash growth in 2008, following observations that patients using it for glaucoma treatment experienced longer, thicker lashes. However, like any medication, it comes with a range of potential adverse effects, so understanding **what are the side effects of bimatoprost for eyelashes?** is crucial for anyone considering its use.

According to clinical trials, the most common side effects reported from using Latisse were eye itching and redness, which occurred in approximately 4% of patients. This FDA-approved prescription eyelash serum, while effective for hypotrichosis, carries potential risks that users must consider, including some that can be permanent.